• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A
Device Problems Torn Material (3024); Insufficient Information (3190)
Patient Problems Corneal Pannus (1447); Aortic Regurgitation (1716)
Event Date 11/16/2017
Event Type  Injury  
Event Description
On (b)(6) 2014, a double valve replacement (dvr) was performed.A 23mm trifecta valve was implanted in the patient's aortic position and an unknown valve in mitral position.On (b)(6) 2017, the patient was admitted to the emergency room due to acute cardiac failure.Upon confirmation of severe aortic regurgitation (ar), re-do avr was urgently performed.The 23mmtrifecta valve was explanted, and a 23mm carpentier-edwards perimount magna aortic heart valve was implanted.Upon explant, one of the leaflets was noted to have been vertically torn and the valve became adhered to the aorta.The sewing cuff of the valve was damaged during explant.The surgeon assumes that uneven operational stress might have been placed on the valve, which may have resulted in the leaflet tear due to the adherence to the aorta.The patient is recovering, and making good progress.Patient specific information of birthdate and weight are not available for this complaint.
 
Manufacturer Narrative
An event of ¿aortic regurgitation¿ was reported.The results of this investigation concluded a tear in leaflet 3.There was circumferential fibrous pannus ingrowth on the inflow surface, which narrowed the inflow diameter.Leaflet 2 contained focal pannus on the outflow surface.No acute inflammation or significant calcifications were present in the valve.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The cause of the reported event remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS  1897-4050
Manufacturer (Section G)
ST. JUDE MEDICAL, COSTA RICA LTDA
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS   1897-4050
Manufacturer Contact
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key7099715
MDR Text Key94239248
Report Number3008452825-2017-00306
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 01/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/09/2016
Device Model NumberTF-23A
Device Catalogue NumberTF-23A
Device Lot Number4526131
Other Device ID Number05414734052030
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/21/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/22/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/10/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-